Financials Xylo Technologies Ltd

Equities

XYLO

US58471G4091

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-04-30 pm EDT 5-day change 1st Jan Change
1.6 USD -4.19% Intraday chart for Xylo Technologies Ltd -29.20% -50.92%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 9.871 7.186 30.22 23.78 7.656 5.656
Enterprise Value (EV) 1 -0.7539 0.3021 7.964 -1.946 -7.259 2.906
P/E ratio -0.81 x -0.48 x -2.95 x 5 x -0.77 x -0.34 x
Yield - - - - - -
Capitalization / Revenue 22.6 x 26.3 x 56.9 x 2.35 x 0.08 x 0.06 x
EV / Revenue -1.73 x 1.11 x 15 x -0.19 x -0.08 x 0.03 x
EV / EBITDA 0.11 x -0.07 x -1.08 x 0.25 x 1.35 x -0.42 x
EV / FCF 0.21 x -0.11 x -2.17 x 0.24 x 12.6 x -0.41 x
FCF Yield 482% -928% -46% 420% 7.95% -244%
Price to Book 1.22 x 1.07 x 1.32 x 0.48 x 0.2 x 0.26 x
Nbr of stocks (in thousands) 253 275 1,055 1,585 1,639 1,735
Reference price 2 39.00 26.10 28.65 15.00 4.670 3.260
Announcement Date 3/28/19 4/21/20 5/14/21 4/29/22 5/3/23 4/22/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.436 0.273 0.531 10.12 91.86 91.72
EBITDA 1 -6.638 -4.175 -7.349 -7.892 -5.385 -6.837
EBIT 1 -6.672 -4.198 -7.465 -8.196 -8.581 -10.82
Operating Margin -1,530.28% -1,537.73% -1,405.84% -81% -9.34% -11.79%
Earnings before Tax (EBT) 1 -6.578 -14.18 -6.841 4.151 -10.1 -21.81
Net income 1 -6.598 -14.18 -4.325 6.794 -9.815 -16.02
Net margin -1,513.3% -5,193.41% -814.5% 67.15% -10.68% -17.47%
EPS 2 -48.00 -54.44 -9.723 3.000 -6.038 -9.504
Free Cash Flow 1 -3.632 -2.803 -3.666 -8.175 -0.5772 -7.094
FCF margin -832.97% -1,026.65% -690.32% -80.8% -0.63% -7.73%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/28/19 4/21/20 5/14/21 4/29/22 5/3/23 4/22/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -3.59
Net margin -
EPS 2 -2.250
Dividend per Share -
Announcement Date 9/23/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 10.6 6.88 22.3 25.7 14.9 2.75
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -3.63 -2.8 -3.67 -8.18 -0.58 -7.09
ROE (net income / shareholders' equity) -97.1% -175% -39.9% 10.4% -19.2% -49.9%
ROA (Net income/ Total Assets) -45.2% -21.4% -20.4% -11.1% -6.82% -8.37%
Assets 1 14.6 66.39 21.17 -61.05 144 191.5
Book Value Per Share 2 31.90 24.40 21.80 30.90 23.80 12.60
Cash Flow per Share 2 42.00 25.60 21.20 15.10 12.20 5.010
Capex 1 0 0.06 0.32 0.14 0.07 0.05
Capex / Sales 0.92% 22.71% 61.02% 1.39% 0.08% 0.06%
Announcement Date 3/28/19 4/21/20 5/14/21 4/29/22 5/3/23 4/22/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. XYLO Stock
  4. Financials Xylo Technologies Ltd